MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gastrointestinal problemsm(also see autonomic dysfunction)"

  • MDS Virtual Congress 2020

    Helicobacter pylori eradication in Parkinson’s disease: A double-blind randomized placebo-controlled study

    A.H Tan, S.Y Lim, S. Mahadeva, M.F Loke, J.S Vadivelu, C. Marras, S.H Fox, A.E Lang (Kuala Lumpur, Malaysia)

    Objective: To evaluate the effects of Helicobacter pylori eradication on PD symptoms. Background: Globally, H. pylori infection remains a common problem. Cross-sectional studies in Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Effect of Lactobacillus casei supplementation on clinical response, gut microbiota and faecal metabolites in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial

    X.D Yang, X.Q He, S.Q Xu, VV. Qian, Y. Zhang, YY. Song, Q. Xiao (Shanghai, China)

    Objective: To evaluate the effect of Lactobacillus casei strain Shirota (LcS) supplementation on symptoms, gut microbiota and faecal metabolites in patients with Parkinson's disease (PD).…
  • MDS Virtual Congress 2020

    Microbiome from Parkinson’s patients shows an increase in polyamines metabolism and differentially expresses microbial bacterial taxa compared to aged-matched normal controls

    S. Melgar, N. Danso, C. Pena, J. Ahmed, S. Kumar, R. Kumar, C. Carlin, D. Linseman, D. Paredes (Denver, CO, USA)

    Objective: The goal of this study was to determine whether the microbiome from Parkinson’s disease (PD) has alterations in a) Polyamine metabolism and b) Expressed…
  • MDS Virtual Congress 2020

    The Gut Dysmotility Questionnaire (GDQ) for Parkinson’s disease: current development

    V. Räder, K.R Chaudhuri, L. Batzu, V. Leta, H. Reichmann, B. Falkenburger, L. Klingelhoefer (Dresden, Germany)

    Objective: To develop a questionnaire to screen for and monitor gastrointestinal symptoms in patients with Parkinson’s disease (PD), entitled Gut Dysmotility Questionnaire (GDQ). Background: Gut…
  • 2019 International Congress

    Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms

    H. Iwaki, M. Tagawa, K. Iwasaki, K. Kawakami, M. Nomoto (Toon, Japan)

    Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…
  • 2019 International Congress

    Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia

    I. Krasakov, I. Litvinenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluat of gut microbiota in patients with Parkinson's disease using a gas chromatography–mass spectrometry Background: An increasing number of studies have reported the…
  • 2019 International Congress

    Gut Feelings about Parkinson’s Disease: The Influence of the Gut Microbiota in a Rodent Model

    A. Gorecki, L. Preskey, M. Bakeberg, J. Kenna, C. Gildenhuys, S. Dunlop, F. Koengten, R. Anderton (Nedlands, Australia)

    Objective: The objective of this study was to investigate the gut microbiota in a pilot cohort of Australian patients with PD, and a rodent model…
  • 2019 International Congress

    Gastrointestinal disorders in various forms of parkinsonism

    R. Matmurodov, KH. Khalimova, EL. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To examine the types of gastrointestinal disorders in parkinsonism, depending on the form of the disease. Background: One of the non-motor autonomic disorders of…
  • 2019 International Congress

    Effect of Levodopa on gut microbiome in Parkinson’s Disease (PD)

    A. Hannoun, D. Ward, J. Flahive, J. Friedman, A. Deb, K. Smith (Worcester, MA, USA)

    Objective: To characterize changes in the gut microbiome in de novo PD subjects before and after initiating carbidopa/levodopa Background: The gastrointestinal microbiome in patients with…
  • 2019 International Congress

    Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients

    J. Kenna, S. Mcgregor, M. Horne, A. Tay, S. Ghosh, F. Mastaglia, A. Jefferson, A. Gorecki, M. Bakeberg, S. Walters, R. Anderton (Perth, Australia)

    Objective: Parkinson’s disease (PD) is associated with an assortment of difficult to recognize non-motor symptoms, including gastrointestinal (GI) dysfunction. Recently, there have been studies reporting…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley